Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtre
Ajouter des filtres








Gamme d'année
2.
Einstein (Säo Paulo) ; 20: eRC5795, 2022.
Article Dans Anglais | LILACS | ID: biblio-1360403

Résumé

ABSTRACT Hyperhidrosis is characterized by excessive sweating and it affects almost 5% of the population. The affected age group is wide, and it can affect from children to elderlies. There are two types of hyperhidrosis: generalized and focal. Treatment depends on the symptoms presented. In more severe cases, radiofrequency sympatholysis and bilateral thoracic sympathectomy are the options. However, recurrence is possible or the postoperative appearance of conditions called compensatory hyperhidrosis or reflex hyperhidrosis. We describe two cases of patients treated with Cannabidiol who had significant and unexpected improvement of hyperhidrosis. The first patient received Cannabidiol specific for public presentations at work, and the second patient had a diagnosis of autism spectrum disorder. The hyperhidrosis improved in both patients immediately after using Cannabidiol.


Sujets)
Humains , Enfant , Cannabidiol/usage thérapeutique , Trouble du spectre autistique , Hyperhidrose/traitement médicamenteux , Sympathectomie , Résultat thérapeutique , Satisfaction des patients
4.
Einstein (Säo Paulo) ; 18: eRC5522, 2020.
Article Dans Anglais | LILACS | ID: biblio-1142879

Résumé

ABSTRACT We report a case of a 61-years-old woman in remission of psoriasis for 20 years. She presented recurrence of psoriasis in the form of plaques few days after taking L-methylfolate 15mg/day. The L-methylfolate was prescribed as an adjuvant for the treatment of depression in a patient with the methylenetetrahydrofolate reductase gene polymorphism (MTHFR).


RESUMO Paciente do sexo feminino, 61 anos, em remissão da psoríase por 20 anos. Apresentou recidiva de psoríase em forma de placas poucos dias após início de tratamento L-metilfolato na dose diária de 15mg. O L-metilfolato foi prescrito como terapêutica coadjuvante para tratamento de depressão em paciente portadora do polimorfismo do gene metilenotetrahidrofolato redutase.


Sujets)
Humains , Femelle , Psoriasis/induit chimiquement , Qualité de vie , Tétrahydrofolates/administration et posologie , Methylenetetrahydrofolate reductase (NADPH2)/déficit , Dépression/traitement médicamenteux , Homocystinurie/complications , Spasticité musculaire/complications , Polymorphisme génétique , Troubles psychotiques/complications , Récidive , Tétrahydrofolates/usage thérapeutique , Résultat thérapeutique , Methylenetetrahydrofolate reductase (NADPH2)/génétique , Adulte d'âge moyen
SÉLECTION CITATIONS
Détails de la recherche